ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,078,444 | +2675.9% | 130,840 | +3555.8% | 0.01% | – |
| Q1 2022 | $255,000 | -94.8% | 3,579 | -94.6% | 0.00% | -100.0% |
| Q3 2021 | $4,935,000 | +23.1% | 65,766 | +28.0% | 0.01% | 0.0% |
| Q2 2021 | $4,009,000 | -30.6% | 51,376 | -27.1% | 0.01% | -47.6% |
| Q1 2021 | $5,773,000 | -55.7% | 70,483 | -55.3% | 0.02% | -59.6% |
| Q4 2020 | $13,026,000 | +826.5% | 157,532 | +628.0% | 0.05% | +766.7% |
| Q3 2020 | $1,406,000 | +379.9% | 21,639 | +357.5% | 0.01% | +500.0% |
| Q2 2020 | $293,000 | -69.2% | 4,730 | -68.2% | 0.00% | -80.0% |
| Q1 2020 | $951,000 | +1967.4% | 14,854 | +2123.7% | 0.01% | – |
| Q4 2019 | $46,000 | -93.3% | 668 | -93.8% | 0.00% | -100.0% |
| Q3 2019 | $686,000 | -34.9% | 10,847 | -34.7% | 0.00% | -40.0% |
| Q2 2019 | $1,053,000 | +27.9% | 16,613 | +57.3% | 0.01% | -16.7% |
| Q3 2018 | $823,000 | – | 10,558 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |